Lakeshore Biopharma Co, Stock Revenue
| LSBPW Stock | 0.04 0 2.83% |
LakeShore Biopharma Co, fundamentals help investors to digest information that contributes to LakeShore Biopharma's financial success or failures. It also enables traders to predict the movement of LakeShore Stock. The fundamental analysis module provides a way to measure LakeShore Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LakeShore Biopharma stock.
LakeShore |
LakeShore Biopharma Co, Company Revenue Analysis
LakeShore Biopharma's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current LakeShore Biopharma Revenue | 573.42 M |
Most of LakeShore Biopharma's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LakeShore Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, LakeShore Biopharma Co, reported 573.42 M of revenue. This is 92.48% lower than that of the Healthcare sector and 22.81% lower than that of the Biotechnology industry. The revenue for all United States stocks is 93.92% higher than that of the company.
LakeShore Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in revenue category among its peers.
LakeShore Fundamentals
| Revenue | 573.42 M | ||||
| EBITDA | (368.66 M) | ||||
| Net Income | (433.46 M) | ||||
| Total Debt | 424.46 M | ||||
| Cash Flow From Operations | (295.23 M) | ||||
| Number Of Employees | 758 | ||||
| Total Asset | 1.51 B | ||||
| Retained Earnings | (2.31 B) | ||||
| Working Capital | 100.94 M | ||||
| Net Asset | 1.51 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.